
Détail de l'auteur
Auteur G. CAMPBELL |
Documents disponibles écrits par cet auteur (5)

![]()
Rapport
M. DUNN ; L. DEGENHARDT ; G. CAMPBELL ; J. GEORGE ; J. JOHNSTON ; S. KINNER ; A. MATTHEWS ; J. NEWMAN ; N. WHITE | Sydney : NDARC (National Drug and Alcohol Research Centre) | 2007The Australian Drug Trends 2006 report presents the findings from the fourth year in which data has been collected in all states and territories in Australia on the markets for ecstasy and related drugs. The Ecstasy and Related Drugs Reporting S[...]![]()
Article : Périodique
N. BLACK ; E. STOCKINGS ; G. CAMPBELL ; L. T. TRAN ; D. ZAGIC ; W. D. HALL ; M. FARRELL ; L. DEGENHARDT |Background: Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain[...]![]()
Article : Périodique
W. HALL ; D. STJEPANOVIC ; J. CAULKINS ; M. LYNSKEY ; J. LEUNG ; G. CAMPBELL ; L. DEGENHARDT |We assess the current and describe possible future public health impacts of the legalisation of cannabis production, sale, and use in the Americas. First, we describe global patterns of cannabis use and their most probable adverse health effects[...]![]()
Article : Périodique
E. ZAHRA ; S. DARKE ; L. DEGENHARDT ; G. CAMPBELL |Background: The most commonly used illicit substance worldwide is cannabis. To date, no national level study of cannabis-related death has been undertaken in Australia. The current study aimed to investigate the rates, characteristics and manner[...]![]()
Article : Périodique
Introduction and Aims. The study aimed to ascertain the association between baseline client characteristics, drug use and psychopathology on length of stay, treatment completion and early separation in drug free therapeutic communities. Design[...]